175 related articles for article (PubMed ID: 35754794)
1. Circular RNAs as Prognostic Biomarkers in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Liao D; Lin Q; Xiao H; Zhang F; Han Q
Front Genet; 2022; 13():878700. PubMed ID: 35754794
[No Abstract] [Full Text] [Related]
2. Circular RNAs as prognostic and diagnostic biomarkers in renal cell carcinoma.
Rashedi S; Mardani M; Rafati A; Khavandi MM; Mohammadi F; Javanshir S; Sarallah R; Dolatshahi M; Sabahi M; Azadnajafabad S; Tavolinejad H; Rezaei N
J Clin Lab Anal; 2022 Oct; 36(10):e24670. PubMed ID: 35989533
[TBL] [Abstract][Full Text] [Related]
3. CircRNAs as promising biomarker in diagnostic and prognostic of lung cancer: An updated meta-analysis.
Yang X; Tian W; Wang S; Ji X; Zhou B
Genomics; 2021 Jan; 113(1 Pt 1):387-397. PubMed ID: 33326833
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated Expression Levels of Circular RNAs Serve as Prognostic and Clinicopathological Markers in Gastric Cancer: a Meta-Analysis.
Zhao G; Wu Y; Wu L; Huang J; Gan Y; Li H
Clin Lab; 2021 Apr; 67(4):. PubMed ID: 33865259
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated circular RNAs as novel biomarkers in esophageal squamous cell carcinoma: a meta-analysis.
Guo C; Mi J; Li H; Su P; Nie H
Cancer Med; 2021 Nov; 10(22):7895-7908. PubMed ID: 34704390
[TBL] [Abstract][Full Text] [Related]
6. The predictive value of circular RNAs in the diagnosis, prognosis and clinicopathological features of thyroid cancer: A systematic review and meta-analysis.
Zhu C; Feng Z; Hong F; Sun H; Wang Z; Zhao Z; Zhang F
Pathol Res Pract; 2022 Aug; 236():153871. PubMed ID: 35797852
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value and clinicopathological features of sarcomatoid differentiation in patients with renal cell carcinoma: a systematic review and meta-analysis.
Zhang L; Wu B; Zha Z; Zhao H; Feng Y
Cancer Manag Res; 2018; 10():1687-1703. PubMed ID: 29970967
[TBL] [Abstract][Full Text] [Related]
8. The prevalence and prognostic and clinicopathological value of PD-L1 and PD-L2 in renal cell carcinoma patients: a systematic review and meta-analysis involving 3,389 patients.
Lu Y; Song Y; Xu Y; Ou N; Liang Z; Hu R; Zhang W; Kang J; Wang X; Liu L; Yang Y; Liu X
Transl Androl Urol; 2020 Apr; 9(2):367-381. PubMed ID: 32420142
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis.
Cheng B; Yang G; Jiang R; Cheng Y; Yang H; Pei L; Qiu X
Oncotarget; 2016 Oct; 7(40):65862-65875. PubMed ID: 27588469
[TBL] [Abstract][Full Text] [Related]
10. The association of platelet count with clinicopathological significance and prognosis in renal cell carcinoma: a systematic review and meta-analysis.
Gu L; Li H; Gao Y; Ma X; Chen L; Li X; Zhang Y; Fan Y; Zhang X
PLoS One; 2015; 10(5):e0125538. PubMed ID: 25955026
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis as a prognostic variable for the clinical outcome in patients with renal cell carcinoma: a systematic review and meta-analysis.
Zhang L; Zha Z; Qu W; Zhao H; Yuan J; Feng Y; Wu B
BMC Cancer; 2018 Sep; 18(1):870. PubMed ID: 30176824
[TBL] [Abstract][Full Text] [Related]
12. Circular RNAs are Potential Prognostic Markers of Head and Neck Squamous Cell Carcinoma: Findings of a Meta-Analysis Study.
Nath M; Roy D; Choudhury Y
Front Oncol; 2022; 12():782439. PubMed ID: 35296016
[TBL] [Abstract][Full Text] [Related]
13. A pair-wise meta-analysis highlights circular RNAs as potential biomarkers for colorectal cancer.
Li C; He X; Zhang L; Li L; Zhao W
BMC Cancer; 2019 Oct; 19(1):957. PubMed ID: 31615475
[TBL] [Abstract][Full Text] [Related]
14. Dysregulated Expression of Circular RNAs Serve as Prognostic and Clinicopathological Markers in Cancer.
Huang X; Zhang Z; Qing X; Zhang W; Zhong B; Deng X; Wang S; Cheng C; Hu H; Shao Z
J Cancer; 2019; 10(8):1825-1832. PubMed ID: 31205539
[No Abstract] [Full Text] [Related]
15. CircRNAs as potential biomarkers for the clinicopathology and prognosis of glioma patients: a meta-analysis.
Ding X; Yang L; Geng X; Zou Y; Wang Z; Li Y; Qi R; Wang W; Li J; Yu H
BMC Cancer; 2020 Oct; 20(1):1005. PubMed ID: 33059605
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and Prognostic Significance of Dysregulated Expression of Circular RNAs in Osteosarcoma.
Zhang C; He J; Qi L; Wan L; Wang W; Tu C; Li Z
Expert Rev Mol Diagn; 2021 Feb; 21(2):235-244. PubMed ID: 33428501
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic value of circRNAs expression in head and neck squamous cell carcinoma: A meta-analysis.
Feng H; Wang D; Liu J; Zou L; Xu S; Liang Z; Qin G
J Clin Lab Anal; 2022 Jul; 36(7):e24496. PubMed ID: 35595945
[TBL] [Abstract][Full Text] [Related]
18. Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2018 May; 480():166-172. PubMed ID: 29462592
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and diagnostic value of circRNA expression in colorectal carcinoma: a meta-analysis.
Yuan J; Guo D; Li X; Chen J
BMC Cancer; 2020 May; 20(1):448. PubMed ID: 32429931
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker for Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
Chen X; Meng F; Jiang R
Front Oncol; 2021; 11():746976. PubMed ID: 34900692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]